Biogen soars 47% after FDA scientists say its Alzheimer's drug's efficacy is 'exceptionally persuasive' | Markets Insider

Generating your feed, please be patient ...

Biogen soars 47% after FDA scientists say its Alzheimer's drug's efficacy is 'exceptionally persuasive' | Markets Insider | Zootzle